From: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy
Time
WHO Class
P-value
I
II
III
Start of Study
3 (8%)
22 (61%)
11 (30%)
After 3 months
5 (14%)
18 (48%)
14 (38%)
0.539